These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23875595)

  • 1. [The yield of tigecycline in the treatment of community-acquired pneumonia].
    Cilli A
    Tuberk Toraks; 2013; 61(2):155-61. PubMed ID: 23875595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.
    Tanaseanu C; Milutinovic S; Calistru PI; Strausz J; Zolubas M; Chernyak V; Dartois N; Castaing N; Gandjini H; Cooper CA;
    BMC Pulm Med; 2009 Sep; 9():44. PubMed ID: 19740418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline: in community-acquired pneumonia.
    McKeage K; Keating GM
    Drugs; 2008; 68(18):2633-44. PubMed ID: 19093704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
    Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience.
    Dartois N; Castaing N; Gandjini H; Cooper A;
    J Chemother; 2008 Oct; 20 Suppl 1():28-35. PubMed ID: 19036672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficacy and safety of tigecycline for treatment of respiratory tract infections: systematic review of literature].
    Moya Cordero P; Ruiz-Aragón J; Molina Linde JM; Márquez-Peláez S; Motiva Sánchez V
    Rev Chilena Infectol; 2013 Dec; 30(6):591-7. PubMed ID: 24522299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tigecycline: a systematic review of clinical experience during first years of prescription].
    Diomedi P A
    Rev Chilena Infectol; 2009 Apr; 26(2):114-25. PubMed ID: 19621142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch therapy in hospitalized patients with community-acquired pneumonia: tigecycline vs. levofloxacin.
    Ramirez JA; Cooper AC; Wiemken T; Gardiner D; Babinchak T;
    BMC Infect Dis; 2012 Jul; 12():159. PubMed ID: 22812672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update for community-acquired bacterial pneumonia pharmacotherapy: what's new and where does it fit?
    DeBellis HF; Jones MC; Kincaid SE
    J Pharm Pract; 2012 Dec; 25(6):569-75. PubMed ID: 23065389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline: an update.
    Stein GE; Babinchak T
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):331-6. PubMed ID: 23357291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tigecycline and occurrence of tetracycline resistance determinants in isolates from patients enrolled in phase 3 clinical trials for community-acquired pneumonia.
    Bradford PA; Petersen PJ; Tuckman M; Jones CH
    Clin Microbiol Infect; 2008 Sep; 14(9):882-6. PubMed ID: 18844692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia.
    Rubino CM; Bhavnani SM; Forrest A; Dukart G; Dartois N; Cooper A; Korth-Bradley J; Ambrose PG
    Antimicrob Agents Chemother; 2012 Jan; 56(1):130-6. PubMed ID: 21968360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tigecycline: a glycylcycline antimicrobial agent.
    Doan TL; Fung HB; Mehta D; Riska PF
    Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin in the treatment of community-acquired pneumonia.
    Noreddin AM; Elkhatib WF
    Expert Rev Anti Infect Ther; 2010 May; 8(5):505-14. PubMed ID: 20455679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline: a review of a new glycylcycline antibiotic.
    Scheinfeld N
    J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.